Rex Tan serves as the Chief Technology Officer at Aevice Health, a pioneering MedTech spin-off from Nanyang Technological University that is dedicated to tackling chronic respiratory diseases—one of the most pressing healthcare challenges of our time. With a strong foundation in technology management and entrepreneurship,...
Rex Tan serves as the Chief Technology Officer at Aevice Health, a pioneering MedTech spin-off from Nanyang Technological University that is dedicated to tackling chronic respiratory diseases—one of the most pressing healthcare challenges of our time. With a strong foundation in technology management and entrepreneurship, Rex is at the helm of innovative projects that leverage cutting-edge research to develop non-invasive wearable devices. These devices are designed to facilitate the early detection of cardiopulmonary abnormalities, enabling healthcare providers to deliver timely and targeted care to patients from the comfort of their homes.
Under Rex's leadership, Aevice Health has made significant strides in integrating advanced sensor technology and data analytics into its product offerings. His expertise in operations management and project management has been instrumental in streamlining the development process, ensuring that the devices not only meet rigorous regulatory standards but also align with the needs of patients and healthcare professionals alike. Rex’s commitment to intellectual property (IP) management has also fortified Aevice’s position in the competitive MedTech landscape, safeguarding innovations that promise to revolutionize patient care.
Rex is passionate about the intersection of science and technology, believing that innovative research can lead to meaningful real-world impact. His vision extends beyond product development; he actively fosters a culture of technopreneurship within the organization, encouraging collaboration and creative problem-solving among teams. As Aevice Health continues to push the boundaries of what is possible in chronic disease management, Rex Tan remains a driving force, dedicated to making a significant impact on global health outcomes.
